Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?

Satish Shanbhag, Vinay Prasad

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?'. Together they form a unique fingerprint.